(Abstracted from BMJ 2016;355:i5662)
Fetal growth assessment is important to identify fetuses with abnormal fetal growth that are at increased risk of perinatal morbidity and mortality. Serial measurement of symphysis-fundal height (SFH) is the recommended, inexpensive, and first-level screening tool in both low- and high-risk pregnancies.
Nuffield Department of Obstetrics & Gynaecology and Oxford Maternal & Perinatal Health Institute, Green Templeton College (A.T.P., E.O.O., J.H., A.L., L.C.I., S.H.K., J.V.); Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology & Musculoskeletal Sciences (E.O.O., D.G.A.), University of Oxford, Oxford, United Kingdom; Center for Perinatal Studies, Swedish Medical Center, and Global Alliance to Prevent Prematurity and Stillbirth, Seattle, WA (M.G.G.); Departamento Materno-Infantil (M.F.d.S.) and Programa de Pós-Graduação em Epidemiologia (M.F.d.S., C.V.), Universidade Federal de Pelotas, Pelotas, Rio Grande do Sul, Brazil; Faculty of Health Sciences, Aga Khan University, Nairobi, Kenya (M.C.); Department of Family & Community Health, Ministry of Health, Muscat, Sultanate of Oman (Y.A.J.); Department of Engineering Science, University of Oxford, Oxford, United Kingdom (J.A.N.); Dipartimento di Scienze Pediatriche e dell’Adolescenza, Cattedra di Neonatologia, Università degli Studi di Torino, Turin, Italy (E.B.); Nagpur INTERGROWTH-21st Research Centre, Ketkar Hospital, Nagpur, India (M.P.); School of Public Health, Peking University, Beijing, China (R.P.); and Division of Women & Child Health, Aga Khan University, Karachi, Pakistan (Z.A.B.)
Topics: antenatal care, Fetal Growth Longitudinal Study, INTERGROWTH-21st Project, symphysis-fundal height.